UP0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ultragenyx Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 21.43 EUR -6.74% Market Closed

Market Cap: €1.9B

U	Ultragenyx Pharmaceutical Inc F:UP0	US
K	Kroger Co XBER:KOG	US
C	China Molybdenum Co Ltd F:D7N	CN
	Compagnie Generale des Etablissements Michelin SCA PAR:ML	FR

Profitability Summary

Ultragenyx Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

84%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

91% > 84%

Negative Operating Margin

-84%

Negative 3Y Average Operating Margin

-103%

Operating Margin is Increasing

-167% > -84%

Negative Net Margin

-91%

Negative 3Y Average Net Margin

-110%

Net Margin is Increasing

-179% > -91%

Negative Free Cash Flow Margin

-76%

Negative 3Y Average Free Cash Flow Margin

-91%

Free Cash Flow Margin is Increasing

-137% > -76%

Exceptional ROE

1 327%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-69%

ROIC is Increasing

-93% > -70%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.